Cardiora Pty Ltd

Level 9, 31 Queen St, Melbourne VIC 3000

ABN: 33 606 313 642

+613 9657 0700

Additional

reading

Our studies:

Nanayakkara S, Mak V, Crannitch K, Byrne MJ, Kaye DM.  Extended Release Oral Milrinone, CRD-102, for Advanced Heart Failure. Am J Cardiol. 2018 Sep 15;122(6):1017-1020.  https://www.ncbi.nlm.nih.gov/pubmed/30064857

Kaye DM, Nanayakkara S, Vizi D, Byrne MJ, Mariani JA.  Effects of Milrinone on Rest and Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol. 2016 May 31;67(21):2554-6.  https://www.ncbi.nlm.nih.gov/pubmed/27230053

Other relevant articles:

Guglin M & Kaufman M.  Inotropes do not Increase Mortality in Advanced Heart Failure.  International Journal of Medicine 2014; 7:237-251  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038527/

Chong L, Satya K, Kim B, Berkowitz R.  Milrinone Dosing and a Culture of Caution in Clinical Practice.  Cardiology in Review 2018; 26:35-42.  https://www.ncbi.nlm.nih.gov/pubmed/29045285

Pinney S & Stevenson L.  Chronic Inotropic Therapy in the Current Era:  Old Wines with New Pairings.  Circulation Heart Failure 2015;8(5):843-846.  https://www.ncbi.nlm.nih.gov/pubmed/26374915

Yanno M, Kohno M, Ohkusa T, Mochizuki M, Yamada J, Kohno M, Hisaoka T, Ono K, Tanigawa T, Kobayashi S, Matsuzaki M.  Effect of Milrinone on Left Ventricular Relaxation and Ca2+ Uptake Function of Cardiac Sarcoplasmic Reticulum.  Am J Physiol Heart Circ Physiol 2000 279; H1898-H1905.  https://www.ncbi.nlm.nih.gov/pubmed/11009478